Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin.
about
Hepatitis C genotype 6: A concise review and response-guided therapy proposalCurrent status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implicationCurrent challenges in viral hepatitis, antimicrobial resistance and the influenza pandemic.Individualisation of antiviral therapy for chronic hepatitis C.Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.New antiviral therapies for chronic hepatitis CSuperior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C.Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011.Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains.Meta-analysis: superior treatment response in Asian patients with hepatitis C virus genotype 6 versus genotype 1 with pegylated interferon and ribavirinEfficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysisEpidemiology and treatment of hepatitis C genotypes 5 and 6Very high prevalence of hepatitis C virus genotype 6 variants in southern Vietnam: large-scale survey based on sequence determination.Role of viral and host factors in interferon based therapy of hepatitis C virus infectionHepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained countryRobust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.Systematic review: epidemiology of hepatitis C genotype 6 and its management.Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam.Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.APASL consensus statements and management algorithms for hepatitis C virus infection.Cost-effectiveness of the highly effective direct-acting antivirals in the treatment of chronic hepatitis C in Hong Kong.HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks.Hepatitis C vaccine. Need of the hour.Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence.Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia.Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy.Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study.Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a.Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C.Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis.KASL clinical practice guidelines: management of hepatitis C.
P2860
Q22305417-9E05794F-2882-429E-B029-6EC2FC5E7E81Q26828972-1D72C778-F15A-4A95-B7E0-7C9DEDC9CC91Q27024231-5481D4DF-5846-440F-A39F-A06995A52335Q30381336-1FA08D02-44A2-45CD-865D-2194DA0F344AQ33390478-AEE779E1-4908-4F5C-B923-E776CE6A9BE2Q33408167-E57E1C55-46D1-4BC5-8F33-46985CAF3B4BQ33559298-BBF8C240-082E-4D4A-99BD-9F34CC8256F2Q33977173-DE944F35-836B-4655-A85B-AA3F220B89D2Q34130399-451EBCB1-9C94-40F0-BC48-D5FE97EC606AQ34365442-8961E38A-E299-4FAA-B6F2-5A4824581361Q34459438-38DBBBA2-6A6F-4178-B518-29171130A2EBQ34533951-1DDFAFCA-EEB8-49D0-BB2C-B2DD7C94AE60Q35153869-862DD152-AD56-44EC-83D8-0A57B64C79B6Q35194590-A98D959B-5570-4DBE-8EAC-A2A5193A4337Q36534673-15F47044-291F-4865-9AFD-09B1D302C981Q37095846-31882B32-4B1B-4B25-87E4-9BF6CC8EF4C1Q37362240-95FC5DC8-4010-4B96-8D93-6DE572555EC8Q37424755-972D1D35-3A0F-48FF-87B2-8DB60FFC0530Q37713053-AF02B7AA-3E3A-4B2B-9A41-DE528F281EB3Q37882006-EBB54FDE-A645-480D-9556-624AC7FBA4BBQ38029258-4DB4435B-55BB-47F5-87B7-4FA6B404C832Q38164114-DA36E26A-A58C-438B-A26E-4FFB7C4DFE91Q38224436-6D05E1AF-B64A-4C0C-B758-D80B26404FFFQ38459012-A060325D-AF3F-4008-9222-C1550A2D0B47Q38552131-67B70014-0A35-4694-AA16-4FBB2723EB3EQ40224995-17444D52-FEF4-4B76-BFDD-9337A1A05ED0Q40229053-84D531DE-470C-4AC2-9DA0-7A5294589061Q41556755-F514BA0A-A393-49C0-AD04-710A777DFECFQ41648353-BCC8A7B1-86E4-485A-8065-D7806C828A44Q41829739-CF4B0471-B417-493A-82D9-2B5A5D36575DQ42211720-29B503F2-39C1-4D2B-9C89-7BDF50AEFA51Q42221723-8BB9C6B6-B8B7-4E6C-AC7E-0FCAA25336A8Q42252312-5C400099-3541-4E08-ADDE-7E7EECAABE57Q42382462-D4694A87-0BE6-4981-8920-219BBCBF2BCDQ42980225-B1069C2B-F55B-4566-8A48-4BA478266636Q43001742-887C59A0-475D-4EC0-996A-4843CC56EBB5Q43244698-962A6E21-2C4E-42B8-A9DA-336697247774Q50262230-32481A55-E408-4687-A96A-BC927688C8D0Q51836024-3B26C0E2-D76E-4EA9-8774-C7B3C55A924B
P2860
Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@ast
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@en
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@nl
type
label
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@ast
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@en
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@nl
prefLabel
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@ast
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@en
Chronic hepatitis C virus geno ...... ated interferon and ribavirin.
@nl
P2093
P50
P356
P1476
Chronic hepatitis C virus geno ...... lated interferon and ribavirin
@en
P2093
Charles Cheng
Danny Wong
John Young
Man-Fung Yuen
P304
P356
10.1086/591252
P407
P577
2008-09-01T00:00:00Z